维普中文期刊产品整合服务
18篇 您的检索式:作者名="Rajesh I"
    题名 作者 年代 出处 被引量
1DARYN-A Distributed Decision-Making Algorithm for Railway Networks: Modeling and Simulation显示文摘Rajesh V I Sumit G 1995IEEE Transactions on Vehicular Technology1995,44,1:1
2Choline Acetyltransferase Activity in Vascular Dementia and Stroke显示文摘Sharp Sally I Francis Paul T Elliott Mark S J Kalaria Rajesh N Bajic Natasha Hortobagyi Tibor Ballard Clive G 2009Dementia and Geriatric Cognitive Disorders2009,,3:1
3Thermal stability of phosphorylated cellulose modified with various transition metals显示文摘KAUR BALJINDER JAIN RAJESH K GUR I S 1986Journal of Analytical and Applied Pyrolysis1986,9,:1
4Gastrointestinal stromal tumors : CT and MRI findings 显示文摘Sandrasegaran K Rajesh A Rushing I) A 2005Eur Radiol2005,15,7:1
5New synthesis of (22R)-lanosta 8,24-dien-3,22 diol(inotodiol) and 23-keto derivatives of lanosterol显示文摘Rajesh K G Reshetova I G Kamernitakii A V 1991Izv Akad Nauk Sssr Ser Khim1991,,11:1
6Transient asym-ptomatic bradycardia in patients with infusional 5-fluroruracil显示文摘Talapatra K Rajesh I Rajesh B 2007J Cancer Res Ther2007,3,3:1
7Nutrient removal in an A^2O - MBR reactor with sludge reduction 显示文摘Rajesh B J Uan D K Yeom I T 2009Bioresour Technol2009,100,16:1
8Simple and Universal HPLC-UV Method to Determine Cimetidine,Ranitidine,Famotidine and Nizatidine in Urine: Application to the Analysis of Ranitidlne and Its Metabolites in Human Volunteers 显示文摘Diane A I A Rajesh P Abdul W B 2007Journal of Chromatography B2007,860,:1
9Zoneplate-array lithography: A low-cost complement or competitor to scanning-electron-beam lithography 显示文摘Smith Henry I Rajesh Menon Amil Patel 2006Microelectronic Engineering2006,,83:1
10The case for diffractive optics in maskless lithography 显示文摘Dario Gil Rajesh Menon Smith H I 2003B21 (6) : 2810 - 28142003,21,6:1
11An investigation on the cyto-toxicity and caspase-mediated apoptotic effect of biologically synthesized silver nanoparticles usingPodophyllum hexan-drum on human cervical carcinoma cells显示文摘Jeyaraj M Rajesh M Arun R Mubarak A D Sathishku-mar G Sivanandhan G I)ev G K Manickavasagam M Premkumar K Thajuddin N 2013Colloids and Surfaces B:Biointerfaces2013,102,:1
12Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil显示文摘Talapatra K Rajesh I Rajesh B 2007J Can Res Ther2007,3,3:1
13Transient asymptomatic bradycardia in patients on infusional 5-fluorouracil显示文摘Talapatra K Rajesh I Rajesh B 2007J Cancer Res Ther2007,3,3:1
14Multidectector row CT of small bowel tumors 显示文摘Ramachandran I Sinha R Rajesh A 2007Clin Radiol2007,62,7:1
15Multidectectorrow CT of small bowel tumors显示文摘Ramachandran I Sinha R Rajesh A 2007Clin Radiol2007,62,7:1
16Value addition of vegetable wastes by solid-state fermentation using Aspergillus niger for use in aquafeed industry显示文摘Rajesh N Joseph I Paul Raj R 2010Waste Management2010,30,11:1
17Online Strategies for Dynamic Power Management in Systems with Multiple Power Saving States显示文摘Sandy I Sandeep S Rajesh G 2003ACM Transactions on Embedded Computing Systems2003,2,3:1
18Retrospective analysis of anti-inflammatory therapies during the first wave of COVID-19 at a community hospital显示文摘BACKGROUND Our understanding of the severe acute respiratory syndrome coronavirus 2 has evolved since the first reported cases in December 2019,and a greater emphasis has been placed on the hyper-inflammatory response in severely ill patients.The purpose of this study was to determine risk factors for mortality and the impact of anti-inflammatory therapies on survival.AIM To determine the impact of various therapies on outcomes in severe coronavirus disease 2019 patients with a focus on anti-inflammatory and immune-modulating agents.METHODS A retrospective analysis was conducted on 261 patients admitted or transferred to the intensive care unit in two community hospitals between March 12,2020 and June 17,2020.Totally 167 patients received glucocorticoid(GC)therapy.Seventythree patients received GC alone,94 received GC and tocilizumab,28 received tocilizumab monotherapy,and 66 received no anti-inflammatory therapy.RESULTS Patient survival was associated with GC use,either alone or with tocilizumab,and decreased vasopressor requirements.Delayed administration of GC was found to decrease the survival benefit of GC therapy.No difference in survival was found with varying anticoagulant doses,convalescent plasma,tocilizumab monotherapy;prone ventilation,hydroxychloroquine,azithromycin,or intravenous ascorbic acid use.CONCLUSION This analysis demonstrated the survival benefit associated with anti-inflammatory therapy of GC,with or without tocilizumab,with the combination providing the most benefit.More studies are needed to assess the optimal timing of anti-inflammatory therapy initiation.Jose I Iglesias Andrew V Vassallo Jesse B Sullivan Yasmine Elbaga Vishal V Patel Nikunjkumar Patel Lydia Ayad Payam Benson Marina Pittiglio Emad Gobran Alexander Clark Wajahat Khan Kaliope Damalas Rajesh Mohan Satyendra P Singh 2021World Journal of Critical Care Medicine2021,10,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费